FORM 8.3
IRISH TAKEOVER
PANEL
DISCLOSURE UNDER
RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES,
2013
DEALINGS BY
PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
- KEY INFORMATION
| Name of person
dealing (Note 1) |
HBK Investments L.P.
on behalf of itself, its subadvisors and its managed funds |
| Company dealt
in |
ALLERGAN PLC |
| Class of relevant
security to which the dealings being disclosed relate (Note
2) |
US $0.0001 Ordinary
Shares |
| Date of
dealing |
10 September 2019 |
- INTERESTS AND SHORT POSITIONS
- Interests and short positions (following dealing) in the class
of relevant security dealt in (Note 3)
|
Long |
Short |
|
Number |
|
(%) |
Number |
|
(%) |
| (1) Relevant
securities |
100 (0.00%) |
29,223
(0.00%) |
| (2)
Derivatives (other than options) |
5,750,000 (1.75%) |
|
| (3) Options and
agreements to purchase/sell |
37,200 (0.01%) |
36,000
(0.01%) |
| Total |
5,787,300 (1.76%) |
65,223
(0.01%) |
- Interests and short positions in relevant securities of the
company, other than the class dealt in (Note 3)
| Class of relevant
security: |
Long |
Short |
|
Number |
|
(%) |
Number |
|
(%) |
| (1) Relevant
securities |
|
|
(2) Derivatives (other than
options) |
|
|
(3) Options and agreements to purchase/sell |
|
|
| Total |
|
|
Ap20
- DEALINGS (Note 4)
- Purchases and sales
Purchase/sale |
Number of relevant securities |
Price per unit (Note 5) |
|
|
|
- Derivatives transactions (other than options transactions)
Product
name,
e.g. CFD |
Nature
of transaction
(Note 6) |
Number
of relevant securities
(Note 7) |
Price
per unit
(Note 5) |
| Total
Return Swap |
Reducing long position |
46,318 |
USD
163.9014 |
- Options transactions in respect of existing relevant
securities
- Writing, selling, purchasing or varying
Product
name,
e.g. call option |
Writing,
selling, purchasing, varying etc. |
Number of securities
to which the option relates (Note 7) |
Exercise
price |
Type, e.g.
American, European etc. |
Expiry date |
Option money
paid/received per unit (Note 5) |
|
|
|
|
|
|
|
- Exercising
Product name,
e.g. call option |
Number of
securities |
Exercise price per
unit (Note 5) |
|
|
|
- Other dealings (including transactions in respect of new
securities) (Note 4)
Nature of transaction
(Note 8) |
Details |
Price per unit
(if applicable) (Note 5) |
|
|
|
Ap21
2.OTHER INFORMATION
Agreements, arrangements or
understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person relating to the
voting rights of any relevant securities under any option referred
to on this form or relating to the voting rights or future
acquisition or disposal of any relevant securities to which any
derivative referred to on this form is referenced. If none, this
should be stated.
None.
Is a Supplemental Form 8 attached? (Note
9)
YES
| Date of
disclosure |
11 September 2019 |
| Contact
name |
Jonathan Brown |
| Telephone
number |
+44 (0)20 7659
1906 |
| If a
connected EFM, name of offeree/offeror with which
connected |
|
| If a
connected EFM, state nature of connection (Note 10) |
|
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE
8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form
8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product
name,
e.g. call option |
Written, or
purchased |
Number of relevant
securities to which the option or derivative relates |
Exercise price
(Note 2) |
Type, e.g.
American, European etc. |
Expiry date |
| Call Option |
Purchased |
20,000 |
USD 135 |
American |
17 Jan 2020 |
| Call Option |
Purchased |
17,200 |
USD 120 |
American |
17 Jan 2020 |
| Put Option |
Purchased |
20,000 |
USD 130 |
American |
17 Jan 2020 |
| Put Option |
Purchased |
16,000 |
USD 120 |
American |
17 Jan 2020 |
Notes
- Where there are open option positions or open derivative
positions (except for CFDs), full details should be given. Full
details of any existing agreements to purchase or to sell must also
be given on this form.
- For all prices and other monetary amounts, the currency must be
stated.
For full details of disclosure requirements, see Rule 8 of the
Rules. If in doubt, consult the Panel.